Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) has a MoatMap StockRank of 17/100 based on Quality (48/100), Value (13/100), and Momentum (41/100) factor scores. The current signal is STRONG SELL. Tonghua Golden-Horse Pharmaceutical is a Chinese pharmaceutical firm. It lacks a global regulatory moat, has low capital efficiency, and does not align with our high-conviction CDMO or biotech themes.
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is a diversified pharmaceutical company engaged in the R&D, manufacture, and sale of chemical drugs, traditional Chinese medicines, and health products. The company is particularly notable for its advanced clinical pipeline in neurodegenerative diseases, including a highly anticipated drug candidate for Alzheimer's disease. Its established manufacturing bases and national sales network support its core therapeutic product lines.
| Price | $3.69 |
| Market Cap | $3.3B |
| P/E (TTM) | 614.00 |
| Price/Book | 10.23 |
| Return on Equity | 1.4% |
| Return on Invested Capital | 3.1% |
| Debt/Equity | 87.17 |
| Gross Margin | 73.1% |
| Operating Margin | 10.1% |
| Revenue Growth | 0.3% |
| Free Cash Flow | $-442K |
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).